- Glycomics, the comprehensive study of glycans in biological systems, is increasingly vital in understanding their roles in various biological processes, disease mechanisms
- The escalating demand for glycomics solutions is primarily fueled by the growing recognition of the significance of glycans in health and disease, widespread adoption of advanced analytical technologies such as mass spectrometry and chromatography, and increasing investments in glycomics research by both public and private entities. The integration of big data analytics and bioinformatics also significantly contributes to this growth
- North America dominates the glycomics market with the largest revenue share of 39.6% in 2024, characterized by its advanced research infrastructure, substantial federal funding for glycomics projects, and strong collaboration between academic institutions and biopharmaceutical companies, driving early adoption of glycomics tools, particularly in the US.
- Asia-Pacific is expected to be the fastest growing region in the glycomics market during the forecast period due to rapid economic development, significant investments in healthcare research, supportive government policies promoting life sciences and biotechnology, and a rising number of research institutes in countries
- Drug discovery & development segment dominates the glycomics market with a market share of 42.8% in 2024, driven by its critical role glycans play in various biological processes relevant to disease mechanisms, making them attractive targets for developing novel drugs and therapies, alongside increasing R&D investments by pharmaceutical and biotechnology companies
